We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack, Bristol-Myers Squibb Australia Pty Ltd, CON-1368
Product name
ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack
Sponsor name
Bristol-Myers Squibb Australia Pty Ltd
Batches
K02194A
Consent start
Consent no.
CON-1368
Duration
The consent is effective from 17 June 2025 until 1 November 2026.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product does not conform because the product label contains the contact
details of the previous sponsor (Celegene Pty Ltd) in place of the current
sponsor (Bristol-Myers Squibb Australia Pty Ltd), following a transfer of the
sponsorship of the products.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines